Evert Johannes Bunschoten

This inventor holds 14 USPTO granted patents, plus 11 CIPO patents and 2 EPO patents. Top assignees: Pantarhei Bioscience B.v., Donesta Bioscience B.v., Ares Trading S.a.. Active years: 2010-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Evert Johannes Bunschoten. Retrieved from https://idiyas.com/inventor/evert-johannes-bunschoten

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 14

% Patents Active = 78.6

CIPO Patents = 11 (Patent Applications = 1)

EPO Patents = 2

Average Co-Inventor Count = 2.5

ph-index = 13

Forward Citations = 378(Granted Patents)

Company Filing History:

11 out of 20

Pantarhei Bioscience B.v.

patents

2 out of 5

Donesta Bioscience B.v.

Years Active: 2010-2019

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10201611 - Pharmaceutical composition comprising estetrol derivatives for use in cancer therapy (2019-02-12),

2. 9561238 - Pharmaceutical compositions comprising estetrol derivatives for use in cancer therapy (2017-02-07),

3. 9040509 - Method of treating human skin and a skin care composition for use in such a method (2015-05-26),

4. 9034854 - Pharmaceutical composition comprising estetrol derivatives for use in cancer therapy (2015-05-19),

5. 8987240 - Pharmaceutical compositions comprising estetrol derivatives for use in cancer therapy (2015-03-24),

6. 8048869 - Pharmaceutical composition for use in hormone replacement therapy (2011-11-01),

7. 8026228 - Estrogenic compounds in combination with progestogenic compounds in hormone-replacement therapy (2011-09-27),

8. 7943604 - Method of treating human skin and a skin care composition for use in such a method (2011-05-17),

9. 7943602 - Pharmaceutical application of 15- or 16-substituted testosterone analogues (2011-05-17),

10. 7923440 - Method of treating or preventing immune mediated disorders and pharmaceutical formulation for use therein (2011-04-12),

11. 7871995 - Drug delivery system comprising a tetrahydroxylated estrogen for use in hormonal contraception (2011-01-18),

12. 7815912 - Method of controlled ovarian hyperstimulation and pharmaceutical kit for use in such method (2010-10-19),

13. 7732430 - Drug delivery system comprising a tetrahydroxilated estrogen for use in hormonal contraception (2010-06-08),

14. 7723320 - Use of estrogen compounds to increase libido in women (2010-05-25),

Title: Evert Johannes Bunschoten - Innovative Dutch Inventor

Introduction: Evert Johannes Bunschoten is a renowned inventor hailing from Heesch, Netherlands, known for his groundbreaking contributions to various fields.

Latest Patents: Evert Johannes Bunschoten holds several patents in the areas of renewable energy technologies, sustainable agriculture, and advanced materials.

Career Highlights: Throughout his career, Evert Johannes Bunschoten has been recognized for his innovative solutions that have significantly impacted industries such as clean energy, agriculture, and manufacturing.

Collaborations: Evert Johannes Bunschoten has collaborated with leading research institutions, universities, and companies worldwide to further develop and implement his inventions on a global scale.

Conclusion: Evert Johannes Bunschoten's dedication to innovation and his passion for creating sustainable solutions have solidified his reputation as a pioneering inventor in the Netherlands and beyond.

Profile summary based on public USPTO records.